EcoR1 Capital’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

EcoR1 Capital’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-487,615	Closed	-$4.86M	–	80
2022 Q3	$4.86M	Sell	487,615 -100,000	-17%	-$993K	0.14%	51
2022 Q2	$5.8M	Hold	587,615	–	–	0.2%	45
2022 Q1	$5.78M	Hold	587,615	–	–	0.18%	49
2021 Q4	$5.73M	Hold	587,615	–	–	0.18%	45
2021 Q3	$5.77M	Buy	587,615 +387,120	+193%	+$3.78M	0.2%	39
2021 Q2	$1.96M	Buy	+200,495	New	+$1.98M	0.07%	58

EcoR1 Capital's FLAC Position: Q4 2022 in Review

EcoR1 Capital sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 487,615 shares — an estimated $4.86M sold.

EcoR1 Capital first reported a position in FLAC in Q2 2021 and held it in 6 quarters. The position peaked at $5.8M in Q2 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

EcoR1 Capital reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
EcoR1 Capital sold 487,615 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $4.86M.
EcoR1 Capital first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
EcoR1 Capital's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $5.8M in Q2 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on EcoR1 Capital's 13F filing for Q4 2022, filed 14 Feb 2023.